HSBC BON.CAP.CERT. 06/25 MRK/ DE000HS3Y2G3 /
24/05/2024 21:40:09 | Chg.-0.590 | Bid21:59:52 | Ask21:59:52 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
152.250EUR | -0.39% | 152.240 Bid Size: 200 |
152.440 Ask Size: 200 |
MERCK KGAA O.N. | - EUR | 27/06/2025 | Call |
GlobeNewswire
07/05
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
06/05
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
04/03
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
21/12/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
14/12/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
17/10/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA